Comparative analysis of CD8+ T cell responses against human cytomegalovirus proteins pp65 and immediate early 1 shows similarities in precursor frequency, oligoclonality, and phenotype

Journal of Infectious Diseases

Volumn 185, Issue 8, 2002, Pages 1025-1034

  Khan, Naeem ^a   Cobbold, Mark ^a   Keenan, Russell ^a   Moss, Paul A H ^a  

^a UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CD57 ANTIGEN; EPITOPE; GAMMA INTERFERON; HLA A ANTIGEN; HUMAN CYTOMEGALOVIRUS PROTEIN PP65; IMMEDIATE EARLY PROTEIN; IMMEDIATE EARLY PROTEIN 1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADULT; ARTICLE; CELL DIFFERENTIATION; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; EFFECTOR CELL; ENZYME LINKED IMMUNOSPOT ASSAY; HLA SYSTEM; HUMAN; HUMAN CELL; HUMAN CYTOMEGALOVIRUS; IMMUNE RESPONSE; IMMUNOASSAY; IMMUNOPHENOTYPING; LYMPHOCYTE CLONE; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; NORMAL HUMAN; PREDICTION; PRIORITY JOURNAL; PROLYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, VIRAL; CD8-POSITIVE T-LYMPHOCYTES; GENES, T-CELL RECEPTOR BETA; HLA-A ANTIGENS; HUMANS; IMMEDIATE-EARLY PROTEINS; IMMUNODOMINANT EPITOPES; INTERFERON TYPE II; PHENOTYPE; PHOSPHOPROTEINS; VIRAL MATRIX PROTEINS;

EID: 0037090155     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/339963     Document Type: Article

References (36)

1. Cytomegalovirus
2. Pre-emptive CD8 T cell immunotherapy of acute cytomegalovirus infection prevents lethal disease, limits the burden of latent viral genome, and reduces the risk of virus recurrence
3. Cytotoxic T lymphocyte response to cytomegalovirus after human allogeneic bone marrow transplantation: Pattern of recovery and correlation with cytomegalovirus infection and disease
4. Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor
5. Human cytomegalovirus-specific cytotoxic T cells: Relative frequency of stage-specific CTL recognizing the 72-kDa immediate early protein and glycoprotein B expressed by recombinant vaccinia viruses
6. Human cytomegalovirus-specific cytotoxic T cells: Their precursor frequency and stage specificity
7. The human CTL response to CMV is dominated by structural protein pp65: Frequency, specificity and TCR usage of pp65-specific CTL
8. Recognition of human cytomegalovirus gene products by HCMV-specific cytotoxic T cells
9. T cell epitope mapping by flow cytometry
10. Target structures of the CD8(+)-T-cell response to human cytomegalovirus: The 72-kDa major immediate-early protein revisited
11. Phenotypic analysis of antigen-specific T lymphocytes
12. Counting antigen-specific CD8 T cells: A re-evaluation of bystander activation during viral infection
13. HLA-peptide tetrameric complexes
14. + T lymphocytes in healthy seropositive donors
15. Cytotoxic T lymphocyte (CTL) responses to human cytomegalovirus pp65, IE1-Exon4, gB, pp150, and pp28 in healthy individuals: Reevaluation of prevalence of IE1-specific CTLs
16. The immunogenicity of human and murine cytomegaloviruses
17. Development of a candidate HLA A*0201 restricted peptide-based vaccine against human cytomegalovirus infection
18. MHC ligands and peptide motifs: First listing
19. Activation of preexisting T cell clones by targeted interleukin-2 therapy
20. Generation of cytomegalovirus specific human T cell clones by using autologous B lymphoblastoid cells with stable expression of pp65 or IE-1 proteins: A tool to study the fine specificity of the antiviral immune response
21. The memory CTL response to HCMV infection contains individual peptide-specific CTL clones that have undergone extensive expansion in vivo
22. Selective interference with class I major histocompatibility complex presentation of the major immediate-early protein following infection with human cytomegalovirus
23. Identification of three HLA-A*0201 - Restricted cytotoxic T cell epitopes in the cytomegalovirus protein pp65 that are conserved between eight strains of the virus
24. Macrophages escape inhibition of major histocompatibility complex class I-dependent antigen presentation by cytomegalovirus
25. Incomplete CD8 T cell differentiation as a mechanism for subdominant viral responses to viral antigen
26. Extensive conservation of alpha and beta chains of the human T-cell antigen receptor recognizing HLA-A2 and influenza A matrix peptide
27. Dominant selection of an invariant T cell antigen receptor in response to persistent infection by Epstein-Barr virus
28. + T-cell population
29. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions
30. Phenotypic and functional separation of memory and effector human CD8 T cells
31. + T cells contain cells with high levels of lymphocyte function-associated antigen-1 expression, a phenotype of primed T cells
32. Monocytes are a major site of persistence of human cytomegalovirus in peripheral blood mononuclear cells
33. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product
34. PCR activity of CMV in healthy CMV-seropositive individuals: Does latency need redefinition?
35. Cytomegalovirus reactivation and tumour necrosis factor
36. + T cells by dendritic cells